Core Insights - CME Group reported an all-time high international average daily volume (ADV) of 8.4 million contracts in 2025, representing an 8% increase from 2024, driven by significant growth in various asset classes [1][4] Group 1: Regional Performance - EMEA ADV reached a record 6.1 million contracts in 2025, up 6% from 2024, with notable increases in Equity Index (25%), Metals (23%), Agricultural (8%), Energy (7%), and Interest Rate products (1%) [2] - APAC ADV grew to an all-time high of 1.9 million contracts in 2025, up 13% from 2024, driven by record growth in Metals (66%), Energy (32%), Agricultural (14%), and Interest Rate products (8%) [3] - Canada ADV achieved a record 180,000 contracts in 2025, up 10% year on year, with records in Equity Index (23%), Interest Rate (6%), Agricultural (3%), and Energy products (1%) [3] - LatAm ADV remained unchanged at 173,000 contracts in 2025, with records in Foreign Exchange (42%), Metals (29%), and Equity Index products (7%) [4] Group 2: Global Performance - Globally, CME Group reported a record ADV of 28.1 million contracts in 2025, up 6% over 2024, primarily driven by record growth in Interest Rate ADV (4% to 14.2 million contracts) and Metals ADV (34%) [4] - Additional records were noted across Agricultural and Energy ADV, both increasing by 8% [4] Group 3: Company Overview - CME Group is recognized as the world's leading derivatives marketplace, providing clients with the ability to trade futures, options, cash, and OTC markets, while also offering tools for risk management and opportunity capture [5]

Core Insights - CME Group Inc. reported record financial results for Q2 2025, with revenue of $1.7 billion, up 10% from Q2 2024, and operating income of $1.1 billion [2][8] - The average daily volume (ADV) reached a record 30.2 million contracts, reflecting a 16% increase year-over-year, driven by heightened demand for benchmark futures and options [2][8] - The company experienced a significant increase in new retail traders, with a 57% year-over-year growth, contributing to a record Micros ADV of 4.1 million contracts [2] Financial Performance - Net income for Q2 2025 was $1.0 billion, with diluted earnings per share at $2.81; on an adjusted basis, net income was $1.1 billion and diluted earnings per share were $2.96 [2][12] - Clearing and transaction fees revenue totaled $1.4 billion, with an average rate per contract of $0.690; market data revenue was $198 million [3][12] - Total revenues for the first six months of 2025 reached $3.334 billion, compared to $3.020 billion for the same period in 2024 [12] Balance Sheet and Shareholder Returns - As of June 30, 2025, CME Group had $2.2 billion in cash and $3.4 billion in debt; the company paid approximately $3.0 billion in dividends during the first half of the year [4] - Since implementing a variable dividend policy in early 2012, CME Group has returned $29.1 billion to shareholders in the form of dividends [4] Market Position and Strategy - CME Group is recognized as the world's leading derivatives marketplace, offering a wide range of global benchmark products across major asset classes [5] - The company continues to enhance its trading platforms and services, including futures and options on futures trading through CME Globex and fixed income trading via BrokerTec [5]

Core Insights - CME Group and CF Benchmarks are launching four new cryptocurrency reference rates and real-time indices for Arbitrum, Ondo, NEAR, and Sui, expanding their suite of cryptocurrency benchmarks [1][2] - The new benchmarks aim to provide transparent pricing data for market participants, covering over 96% of the investible cryptocurrency market capitalization [2][4] - These reference rates will utilize pricing data from multiple exchanges, ensuring accuracy and reliability in the cryptocurrency ecosystem [3][4] Company Overview - CME Group is recognized as the world's leading derivatives marketplace, facilitating trading across various asset classes and providing a platform for risk management [6] - CF Benchmarks is a regulated cryptocurrency index provider, authorized under the UK Benchmarks Regulation, and offers transparent methodologies for tracking and valuing cryptocurrency products [8][9] - The indices from CF Benchmarks are integrated into significant regulated crypto products, including a majority of spot bitcoin ETFs in the US and a substantial portion of the regulated crypto derivatives market [10]